E Fund Management (HK)
ABBV icon

E Fund Management (HK)’s AbbVie ABBV Stock Holding History

E Fund Management (HK)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$681K Buy
2,602
+1,314
+102% +$337K 0.15% 89
2026
Q2 		$324K Buy
1,288
+1,013
+368% +$218K 0.11% 122
2026
Q1 		$59.8K Buy
275
+225
+450% +$49.9K 0.03% 169
2025
Q4 		$11.3K Buy
50
+33
+194% +$7.52K ﹤0.01% 198
2025
Q3 		$3.94K Buy
+17
New +$3.46K ﹤0.01% 156

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

E Fund Management (HK)'s ABBV Position: Q3 2026 in Review

E Fund Management (HK) increased its AbbVie (ABBV) stake by 102% in Q3 2026, buying an estimated $337K and bringing the position to 2,602 shares worth $681K. The position accounts for 0.15% of the portfolio, ranked #89.

E Fund Management (HK) first reported a position in ABBV in Q3 2025 and has held it in 5 quarters since. 3,769 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • E Fund Management (HK) held 2,602 shares of AbbVie worth $681K as of Q3 2026.
  • E Fund Management (HK) bought 1,314 AbbVie shares in Q3 2026, an estimated $337K.
  • AbbVie made up 0.15% of E Fund Management (HK)'s portfolio in Q3 2026, its #89 holding.
  • E Fund Management (HK) first reported a position in AbbVie in Q3 2025 and has held it in 5 quarters since.
  • 3,769 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on E Fund Management (HK)'s 13F filing for Q3 2026, filed 12 Nov 2026.